LENZ Therapeutics, Inc announced it has entered into a stock purchase agreement with new investor, Ridgeback Capital Investments L.P. for gross proceeds $30,000,000 on July 15, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.44 USD | +3.36% |
|
+20.55% | 0.00% |
15/07 | Lenz Therapeutics Signs $30 Million Stock PIPE Deal With Ridgeback Capital | MT |
15/07 | LENZ Therapeutics, Inc. announced that it expects to receive $30 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 55Cr | |
+21.25% | 13TCr | |
+24.39% | 12TCr | |
+25.44% | 2.77TCr | |
-18.94% | 2.03TCr | |
-15.17% | 1.68TCr | |
-16.33% | 1.56TCr | |
+12.70% | 1.48TCr | |
-47.10% | 1.46TCr | |
+57.11% | 1.44TCr |
- Stock Market
- Equities
- LENZ Stock
- News LENZ Therapeutics, Inc.
- LENZ Therapeutics, Inc. announced that it expects to receive $30 million in funding